knowledge -WSS

knowledge

author：leisure time 2025-10-01 05:38:56 - browse：36

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Cancer drug shortages should be causing more outrage
Next article： How AI helped researchers track recovery from depression

WSS

Argenx drug significantly slows progression of nerve disorder

Blood tests recalled over risk of missed heart attack diagnosis

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

How Vertex's cystic fibrosis drug is changing patients' lives

Why are Kaiser Permanente staff considering a strike?

It's been 20 years since Dolly the sheep. Where's my clone?

explore

knowledge

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why police arrested suspected Gilgo Beach killer away from his house

BioMarin wins approval for gene therapy to treat hemophilia A

Readout LOUD podcast: possible new ALS drug, artificial wombs

In Memoriam: Notable people who died in 2023

How AI helped researchers track recovery from depression

Heart attack and stroke risk calculators need revising

Drug for rare kidney disease narrowly misses mark in clinical trial

Drug repurposing or repositioning? The language matters

Ukraine and a new approach to mental health in war

entertainment

J&J expands global access to TB drug amid advocacy campaign

Changes to biosimilar regulatory framework must prioritize patients

Georgia court denies Trump's request to quash DA's 2020 election probe

Thermo Fisher plant for manufacturing gene therapies to expand

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Grail faces three suits alleging harassment, retaliation

entertainment

entertainment

explore

focus